jet injector

(redirected from Biojector)
Also found in: Wikipedia.

jet in·jec·tor

an injector that uses high pressure to force a liquid through a small orifice at a velocity sufficient to penetrate skin or mucous membrane without the use of a needle.

injector

(in-jek'tor)
A device for making injections.

jet injector

See: injection, jet

pressure injector

A device that delivers a substance to be injected, often controlled by a timing mechanism, at a specified pressure.

jet in·jec·tor

(jet in-jektŏr)
Device that employs high pressure to force liquid through a small orifice at a velocity sufficient to penetrate skin or mucous membrane without a needle.
References in periodicals archive ?
1 Biojector 2000: Adaptable Power Source Allows Use in Home and Mass Vaccination Setting 7.
Speaking of the flu, available this fall at Fred Meyer stores is new needle-free option called the Biojector 2000.
Bioject offers several proprietary delivery technologies, including Biojector 2000, Cool.
The new information focuses on side effects reported when the Biojector 2000 needle-free device is used to inject Fuzeon.
Some people are exploring the needle-free Biojector 2000, made by Bioject Medical Technologies Inc.
CASE FACTS: A nurse employed by the Metropolitan Visiting Nurse Association (MVNA) administered a flu shot to Lynn Donovan using a Biojector 2000.
The Biojector offers patients a safe, easy and convenient alternative to the needle and syringe for their annual flu shot," said Dr.
Products include the Biojector 2000, Vial Adapter and Bioject Zetajet(TM)
FlashMed will be the exclusive distributor of the Biojector 2000 needle-free injection system and the Bioject ZetaJet(TM) portable injector products in Ecuador.
Products positioned for distribution through this agreement include the full portfolio of Bioject technologies including the Biojector 2000 needle-free injection system and theBioject ZetaJet(TM) portable injector.
Presentation Jeffrey Currier, United States Military HIV Research Program; Inovio collaborator "Cell-mediated immune responses after DNA delivered by either Biojector or electroporation and boosted with a heterologous insert recombinant poxvirus" September 13, 2011
We attribute the decline to the withdrawal of the sNDA for Biojector 2000 along with approvals of competitors Selzentry and Isentress.